Skip to search formSkip to main contentSkip to account menu

Enduracin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
AIM To evaluate efficacy of combined use of moderate exercise and nicotinic acid drug enduracin in patients with coronary heart… 
2004
2004
It is well known now that hypolipidemic therapy is able to inhibit development of atherosclerosis. This decreases the rate of… 
1999
1999
AIM To analyze lipid and non-lipid effects of 6-month administration of enduracine in patients with marked dislipoproteinemia… 
1998
1998
Enduracin is a new medication form of nicotinic acid, which will probably return this agent to the group of drugs most frequently… 
1997
1997
13 patients aged 39 to 60 years with coronary atherosclerosis confirmed at selective coronary angiography combined with primary… 
1997
1997
13 patients aged 39 to 60 years with coronary atherosclerosis confirmed at selective coronary angiography combined with primary… 
1996
1996
The prevalence of hypercholesterolemia in flying personnel is presented. It is related to duration of service. Correction of… 
1993
1993
The hypolipidemic effects of induracin, a new long-acting nicotinic acid dosage form based on the waxy matrix, and its tolerance…